Novartis loses initial bid to block generic of best-selling heart drug
Novartis failed to persuade a federal court to bar generics maker MSN Pharmaceuticals from marketing its own version of Entresto, Novartis’ favoured drug, according to a court ruling on Monday.
ПОПУЛЯРНЫЕ ПОСТЫ
Poland prepares for peaking floods
Сентябрь 20, 2024
Italy evacuates thousands as Boris hits the north
Сентябрь 20, 2024
China and the US race to tame nuclear fusion for clean energy
Сентябрь 20, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ